Shionogi Inc. FDA Inspection Record

FEI 3004530896 · Inspections, Form 483s, warning letters and import refusals

Shionogi Inc. is an FDA-inspected facility (FEI 3004530896) located in Alpharetta, GA, US. RegDataLab tracks 8 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Feb 15, 2018: No Action Indicated (NAI)
Inspections on record
8 (4 VAI, 4 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
9, latest May 24, 2017
Import refusals
2

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Feb 15, 2018No Action Indicated (NAI)No citations listed
Feb 2, 2015Voluntary Action Indicated (VAI)SOPs not followed / documented (21 CFR 211.100(b))
Following/documenting laboratory controls (21 CFR 211.160(a))
Annual visual exams of drug products (21 CFR 211.170(b))
May 16, 2013Voluntary Action Indicated (VAI)No citations listed
Feb 8, 2012No Action Indicated (NAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Determination not to conduct investigation of complaint (21 CFR 211.198(b)(3))
Written record of investigation incomplete (21 CFR 211.192)
Jul 9, 2010Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Investigations of discrepancies, failures (21 CFR 211.192)
Approval and review of procedures (21 CFR 211.100(a))
Investigations made into any unexplained discrepancy (21 CFR 211.188(b)(12))
and 3 more
Jul 9, 2010No Action Indicated (NAI)No citations listed
Jan 15, 2009Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
SOPs not followed / documented (21 CFR 211.100(b))
Investigations of discrepancies, failures (21 CFR 211.192)
Extent of discrepancy, failure investigations (21 CFR 211.192)
and 4 more
Jan 15, 2009No Action Indicated (NAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
May 24, 2017Class IIID-0219-2018Mefenamic Acid Capsules, USP, 250 mg, 30-count bottle, Rx only, Distributed by Prasco…
Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release…
May 24, 2017Class IIID-0981-2017Mefenamic Acid, 250mg capsules, packaged in 30-count bottles, Rx Only, Distributed by… and 1 more product
Failed Dissolution Specifications: Low dissolution results were obtained during stability testing
Jul 24, 2015Class IIID-1284-2015Nisoldipine Extended Release Tablets, 17 mg, packaged as a) Sular (nisoldipine) Extended…
Failed Dissolution Specifications
Mar 8, 2012Class IID-1398-2012Nisoldipine Extended Release Tablets, 17mg, 100 count bottle, Rx only, Manufactured for…
Failed USP Dissolution Test Requirements: Out of Specification dissolution result at 18 month time point
Dec 23, 2010Class IID-210-2011SULAR (nisoldipine) Extended Release 25.5 mg tablets, Rx only, 100 Tablets, Manufactured… and 1 more product
The product failed dissolution testing at 8 hours at the 12-month stability testing time point.
Oct 28, 2010Class IID-109-2011Twinject¿ (epinephrine injection, USP, 1:1000) auto-injector 0.3 mg, Two Pack, Rx only… and 2 more products
Lack of Assurance of Sterility: Possibility exists a small number of sheaths covering the needle may have pinholes.
Sep 23, 2009Class IIID-031-2010Twinject ¿ 0.3 mg Auto-Injector (epinephrine injection, USP 1:1000), Rx only, Manufactured…
Defective Delivery System; High Force-To-Fire values for the 12 month pull performance testing of Twinject 2008 annual stability units
Aug 3, 2009Class IID-1889-2009Fenoglide (fenofibrate) tablets, 120 mg, 7 tablet Professional Sample bottle, Rx only…
The product may lack efficacy due to the Out of Specification dissolution result at the 9-month stability pull point.
Jul 11, 2008Class IID-042-2009Fenoglide (Fenofibrate) Tablets, 120 mg, 7 Count Bottles, Rx only, Physician Samples…
Failed Dissolution Specifications; 3-month stability

FDA record score

0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

9 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIFeb 2, 201510 years or older, so it adds no points0
Inspection classified VAIMay 16, 201310 years or older, so it adds no points0
Class II recall D-1398-2012, this FEI as the recalling firmMar 8, 201210 years or older, so it adds no points0
Class II recall D-210-2011, this FEI as the recalling firmDec 23, 201010 years or older, so it adds no points0
Class II recall D-109-2011, this FEI as the recalling firmOct 28, 201010 years or older, so it adds no points0
Inspection classified VAIJul 9, 201010 years or older, so it adds no points0
Class II recall D-1889-2009, this FEI as the recalling firmAug 3, 200910 years or older, so it adds no points0
Inspection classified VAIJan 15, 200910 years or older, so it adds no points0
Class II recall D-042-2009, this FEI as the recalling firmJul 11, 200810 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Shionogi Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Shionogi Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Shionogi Inc.
Location
Alpharetta, GA (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.